4.5 Editorial Material

Rich tapestry of G protein-coupled receptor signaling and regulatory mechanisms

期刊

MOLECULAR PHARMACOLOGY
卷 74, 期 2, 页码 312-316

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.108.049015

关键词

-

资金

  1. NEI NIH HHS [R01 EY011500-12, R01 EY011500] Funding Source: Medline
  2. NIGMS NIH HHS [R01 GM081756, R01 GM077561, R01 GM077561-02, R01 GM081756-01A1] Funding Source: Medline
  3. NINDS NIH HHS [R01 NS045117-05, R01 NS045117] Funding Source: Medline

向作者/读者索取更多资源

G protein-coupled receptors (GPCRs) are the largest family of signaling proteins and the most common therapeutic targets. In the last 2 decades, impressive progress in the understanding of GPCR function has been achieved, driven largely by the idea of similarity of the molecular mechanisms underlying their signaling and regulation. However, recent comprehensive studies of signaling and trafficking of several GPCR subtypes, including endogenous M3 muscarinic and H1 histamine receptor and expressed cysteinyl leukotriene type 1 receptor in human embryonic kidney 293 cells, clearly demonstrate that each receptor is regulated by a unique set of molecular mechanisms involving different players. These data indicate that the gold mine of similarities is nearly exhausted and that extrapolation from one receptor to another is as likely to be misleading as illuminating. Further progress in the field requires careful analysis of the regulation of individual GPCR subtypes in defined cellular context. In this issue of Molecular Pharmacology, Luo et al. (p. 338) describe a complex pattern of the regulation of M3 muscarinic receptor signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据